avatar

TEGUH ARYANDONO

Universitas Gadjah Mada Unknown SINTA ID : 6040587
2.304
SINTA Score Overall
494
SINTA Score 3Yr
2.304
Affil Score
494
Affil Score 3Yr
Latest number of activities
PENGEMBANGAN OBAT BERBASIS OLIGONUCLEOTIDE-NANOPARTICLES INNULIN CONJUGATED ANTOBODI SEBAGAI SUATU PENDEKATAN OBAT KANKER BERBASIS TARGETED THERAPY
Leader : Sumadi Lukman Anwar Penelitian Desentralisasi ( PPUPT )
Personils : Sofia Mubarika Harjana Teguh Aryandono;
2020 Rp. 247.562.500 Approved BIMA SOURCE
DELETION OF 9P21 LOCUS AND ASSOCIATION WITH BRAF AND NRAS MUTATIONS WITH HIGHTENED RISK OF MELANOMA
Leader : Teguh Aryandono HIBAH DANA MASYARAKAT FKKMK UGM ( DOSEN MAHASISWA PPDS )
Personils : -
2020 Rp. 30.000.000 Approved INTERNAL SOURCE
STATUS IMUN BASELINE DAN EKSPRESI PD-L1 PADA KANKER PAYUDARA SUBTIPE HER2-ENRICHED DAN TRIPLE-NEGATIVE UNTUK PREDIKSI RESPON TERAPI DENGAN IMMUNE-CHECKPOINT INHIBITOR
Leader : Sumadi Lukman Anwar HIBAH PENELITIAN DAMAS FK-KMK UGM ( DOSEN MAHASISWA PPDS )
Personils : Teguh Aryandono;
2020 Rp. 30.000.000 Approved INTERNAL SOURCE
MIRNA GENOME SIGNATURE OF INDONESIAN EBV RELATED NASOPHARYNGEAL CARCINOMA IN THE DEVELOPMENT OF TARGETED THERAPY FOR PERSONALIZED MEDICINE
Leader : Sofia Mubarika Harjana Penelitian Kompetitif Nasional ( PD )
Personils : Indwiani Astuti; Teguh Aryandono;
2019 Rp. 220.000.000 Approved BIMA SOURCE
PENGEMBANGAN OBAT BERBASIS OLIGONUCLEOTIDE-NANOPARTICLES INNULIN CONJUGATED ANTOBODI SEBAGAI SUATU PENDEKATAN OBAT KANKER BERBASIS TARGETED THERAPY
Leader : Sumadi Lukman Anwar Penelitian Desentralisasi ( PPUPT )
Personils : Sofia Mubarika Harjana Teguh Aryandono;
2019 Rp. 170.000.000 Approved BIMA SOURCE
PENGEMBANGAN OBAT BERBASIS OLIGONUCLEOTIDE- NANOPARTICLES INNULIN CONJUGATED ANTOBODI SEBAGAI SUATU PENDEKATAN OBAT KANKER BERBASIS TARGETED THERAPY
Leader : Sumadi Lukman Anwar HIBAH DANA MASYARAKAT FKKMK UGM ( DOSEN MAHASISWA S2 )
Personils : Teguh Aryandono; Sofia Mubarika Harjana;
2019 Rp. 30.000.000 Approved INTERNAL SOURCE
PENGEMBANGAN BIOMARKER DIAGNOSIS EARLY STAGE untuk CIRHOSIS HEPATIS ( CH) MENUJU HEPATOCELLULAR CARCINOMA ( HCC) : SUATU UPAYA PREVENTIF DI ERA INDIVIDUALIZED MEDICINE
Leader : Sofia Mubarika Harjana Insinas ( IRPI )
Personils : Teguh Aryandono; Indwiani Astuti;
2018 Rp. 315.500.000 Approved BIMA SOURCE
PENGEMBANGAN OBAT BERBASIS OLIGONUCLEOTIDE-NANOPARTICLES INNULIN CONJUGATED ANTOBODI SEBAGAI SUATU PENDEKATAN OBAT KANKER BERBASIS TARGETED THERAPY
Leader : Sumadi Lukman Anwar Penelitian Desentralisasi ( PPUPT )
Personils : Sofia Mubarika Harjana Teguh Aryandono;
2018 Rp. 243.000.000 Approved BIMA SOURCE
MicroRNA binding sites pada Rs4245739, pengaruh terhadap MDM4 dan TP53: pemanfaataannya untuk biomarker dan terapi target pada kanker payudara
Leader : Sumadi Lukman Anwar Penelitian Desentralisasi ( PTUPT )
Personils : Teguh Aryandono; Sofia Mubarika Harjana
2018 Rp. 115.000.000 Approved BIMA SOURCE
MIRNA GENOME SIGNATURE OF INDONESIAN EBV RELATED NASOPHARYNGEAL CARCINOMA IN THE DEVELOPMENT OF TARGETED THERAPY FOR PERSONALIZED MEDICINE
Leader : Sofia Mubarika Harjana Penelitian Kompetitif Nasional ( PD )
Personils : Teguh Aryandono; Indwiani Astuti;
2018 Rp. 80.000.000 Approved BIMA SOURCE
View more ...
Get More with SINTA Insight
Go to Insight

Summary

Article Quartile
Research Output
  Scopus GScholar WOS
Article 75 151 0
Citation 916 2372 0
Cited Document 72 110 0
H-Index 18 24
i10-Index 31 46
G-Index 2 1
Get More with SINTA Insight

Go to Insight